The Prevalence and Overlap of Interstitial Cystitis/Bladder Pain Syndrome and Chronic Prostatitis/Chronic Pelvic Pain Syndrome in Men: Results of the RAND Interstitial Cystitis Epidemiology Male Study
Purpose As part of the RICE (RAND Interstitial Cystitis Epidemiology) study, we developed validated case definitions to identify interstitial cystitis/bladder pain syndrome in women and chronic prostatitis/chronic pelvic pain syndrome in men. Using population based screening methods, we applied thes...
Saved in:
Published in | The Journal of urology Vol. 189; no. 1; pp. 141 - 145 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
New York, NY
Elsevier Inc
01.01.2013
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Purpose As part of the RICE (RAND Interstitial Cystitis Epidemiology) study, we developed validated case definitions to identify interstitial cystitis/bladder pain syndrome in women and chronic prostatitis/chronic pelvic pain syndrome in men. Using population based screening methods, we applied these case definitions to determine the prevalence of these conditions in men. Materials and Methods A total of 6,072 households were contacted by telephone to screen for men who had symptoms of interstitial cystitis/bladder pain syndrome or chronic prostatitis/chronic pelvic pain syndrome. An initial 296 men screened positive, of whom 149 met the inclusionary criteria and completed the telephone interview. For interstitial cystitis/bladder pain syndrome 2 case definitions were applied (1 with high sensitivity and 1 with high specificity), while for chronic prostatitis/chronic pelvic pain syndrome a single case definition (with high sensitivity and specificity) was used. These case definitions were used to classify subjects into groups based on diagnosis. Results The interstitial cystitis/bladder pain syndrome weighted prevalence estimates for the high sensitivity and high specificity definitions were 4.2% (3.1–5.3) and 1.9% (1.1–2.7), respectively. The chronic prostatitis/chronic pelvic pain syndrome weighted prevalence estimate was 1.8% (0.9–2.7). These values equate to 1,986,972 (95% CI 966,042–2,996,924) men with chronic prostatitis/chronic pelvic pain syndrome and 2,107,727 (95% CI 1,240,485–2,974,969) men with the high specificity definition of interstitial cystitis/bladder pain syndrome in the United States. The overlap between men who met the high specificity interstitial cystitis/bladder pain syndrome case definition or the chronic prostatitis/chronic pelvic pain syndrome case definition was 17%. Conclusions Symptoms of interstitial cystitis/bladder pain syndrome and chronic prostatitis/chronic pelvic pain syndrome are widespread among men in the United States. The prevalence of interstitial cystitis/bladder pain syndrome symptoms in men approaches that in women, suggesting that this condition may be underdiagnosed in the male population. |
---|---|
AbstractList | As part of the RICE (RAND Interstitial Cystitis Epidemiology) study, we developed validated case definitions to identify interstitial cystitis/bladder pain syndrome in women and chronic prostatitis/chronic pelvic pain syndrome in men. Using population based screening methods, we applied these case definitions to determine the prevalence of these conditions in men.
A total of 6,072 households were contacted by telephone to screen for men who had symptoms of interstitial cystitis/bladder pain syndrome or chronic prostatitis/chronic pelvic pain syndrome. An initial 296 men screened positive, of whom 149 met the inclusionary criteria and completed the telephone interview. For interstitial cystitis/bladder pain syndrome 2 case definitions were applied (1 with high sensitivity and 1 with high specificity), while for chronic prostatitis/chronic pelvic pain syndrome a single case definition (with high sensitivity and specificity) was used. These case definitions were used to classify subjects into groups based on diagnosis.
The interstitial cystitis/bladder pain syndrome weighted prevalence estimates for the high sensitivity and high specificity definitions were 4.2% (3.1–5.3) and 1.9% (1.1–2.7), respectively. The chronic prostatitis/chronic pelvic pain syndrome weighted prevalence estimate was 1.8% (0.9–2.7). These values equate to 1,986,972 (95% CI 966,042–2,996,924) men with chronic prostatitis/chronic pelvic pain syndrome and 2,107,727 (95% CI 1,240,485–2,974,969) men with the high specificity definition of interstitial cystitis/bladder pain syndrome in the United States. The overlap between men who met the high specificity interstitial cystitis/bladder pain syndrome case definition or the chronic prostatitis/chronic pelvic pain syndrome case definition was 17%.
Symptoms of interstitial cystitis/bladder pain syndrome and chronic prostatitis/chronic pelvic pain syndrome are widespread among men in the United States. The prevalence of interstitial cystitis/bladder pain syndrome symptoms in men approaches that in women, suggesting that this condition may be underdiagnosed in the male population. As part of the RICE (RAND Interstitial Cystitis Epidemiology) study, we developed validated case definitions to identify interstitial cystitis/bladder pain syndrome in women and chronic prostatitis/chronic pelvic pain syndrome in men. Using population based screening methods, we applied these case definitions to determine the prevalence of these conditions in men.PURPOSEAs part of the RICE (RAND Interstitial Cystitis Epidemiology) study, we developed validated case definitions to identify interstitial cystitis/bladder pain syndrome in women and chronic prostatitis/chronic pelvic pain syndrome in men. Using population based screening methods, we applied these case definitions to determine the prevalence of these conditions in men.A total of 6,072 households were contacted by telephone to screen for men who had symptoms of interstitial cystitis/bladder pain syndrome or chronic prostatitis/chronic pelvic pain syndrome. An initial 296 men screened positive, of whom 149 met the inclusionary criteria and completed the telephone interview. For interstitial cystitis/bladder pain syndrome 2 case definitions were applied (1 with high sensitivity and 1 with high specificity), while for chronic prostatitis/chronic pelvic pain syndrome a single case definition (with high sensitivity and specificity) was used. These case definitions were used to classify subjects into groups based on diagnosis.MATERIALS AND METHODSA total of 6,072 households were contacted by telephone to screen for men who had symptoms of interstitial cystitis/bladder pain syndrome or chronic prostatitis/chronic pelvic pain syndrome. An initial 296 men screened positive, of whom 149 met the inclusionary criteria and completed the telephone interview. For interstitial cystitis/bladder pain syndrome 2 case definitions were applied (1 with high sensitivity and 1 with high specificity), while for chronic prostatitis/chronic pelvic pain syndrome a single case definition (with high sensitivity and specificity) was used. These case definitions were used to classify subjects into groups based on diagnosis.The interstitial cystitis/bladder pain syndrome weighted prevalence estimates for the high sensitivity and high specificity definitions were 4.2% (3.1-5.3) and 1.9% (1.1-2.7), respectively. The chronic prostatitis/chronic pelvic pain syndrome weighted prevalence estimate was 1.8% (0.9-2.7). These values equate to 1,986,972 (95% CI 966,042-2,996,924) men with chronic prostatitis/chronic pelvic pain syndrome and 2,107,727 (95% CI 1,240,485-2,974,969) men with the high specificity definition of interstitial cystitis/bladder pain syndrome in the United States. The overlap between men who met the high specificity interstitial cystitis/bladder pain syndrome case definition or the chronic prostatitis/chronic pelvic pain syndrome case definition was 17%.RESULTSThe interstitial cystitis/bladder pain syndrome weighted prevalence estimates for the high sensitivity and high specificity definitions were 4.2% (3.1-5.3) and 1.9% (1.1-2.7), respectively. The chronic prostatitis/chronic pelvic pain syndrome weighted prevalence estimate was 1.8% (0.9-2.7). These values equate to 1,986,972 (95% CI 966,042-2,996,924) men with chronic prostatitis/chronic pelvic pain syndrome and 2,107,727 (95% CI 1,240,485-2,974,969) men with the high specificity definition of interstitial cystitis/bladder pain syndrome in the United States. The overlap between men who met the high specificity interstitial cystitis/bladder pain syndrome case definition or the chronic prostatitis/chronic pelvic pain syndrome case definition was 17%.Symptoms of interstitial cystitis/bladder pain syndrome and chronic prostatitis/chronic pelvic pain syndrome are widespread among men in the United States. The prevalence of interstitial cystitis/bladder pain syndrome symptoms in men approaches that in women, suggesting that this condition may be underdiagnosed in the male population.CONCLUSIONSSymptoms of interstitial cystitis/bladder pain syndrome and chronic prostatitis/chronic pelvic pain syndrome are widespread among men in the United States. The prevalence of interstitial cystitis/bladder pain syndrome symptoms in men approaches that in women, suggesting that this condition may be underdiagnosed in the male population. Purpose As part of the RICE (RAND Interstitial Cystitis Epidemiology) study, we developed validated case definitions to identify interstitial cystitis/bladder pain syndrome in women and chronic prostatitis/chronic pelvic pain syndrome in men. Using population based screening methods, we applied these case definitions to determine the prevalence of these conditions in men. Materials and Methods A total of 6,072 households were contacted by telephone to screen for men who had symptoms of interstitial cystitis/bladder pain syndrome or chronic prostatitis/chronic pelvic pain syndrome. An initial 296 men screened positive, of whom 149 met the inclusionary criteria and completed the telephone interview. For interstitial cystitis/bladder pain syndrome 2 case definitions were applied (1 with high sensitivity and 1 with high specificity), while for chronic prostatitis/chronic pelvic pain syndrome a single case definition (with high sensitivity and specificity) was used. These case definitions were used to classify subjects into groups based on diagnosis. Results The interstitial cystitis/bladder pain syndrome weighted prevalence estimates for the high sensitivity and high specificity definitions were 4.2% (3.1–5.3) and 1.9% (1.1–2.7), respectively. The chronic prostatitis/chronic pelvic pain syndrome weighted prevalence estimate was 1.8% (0.9–2.7). These values equate to 1,986,972 (95% CI 966,042–2,996,924) men with chronic prostatitis/chronic pelvic pain syndrome and 2,107,727 (95% CI 1,240,485–2,974,969) men with the high specificity definition of interstitial cystitis/bladder pain syndrome in the United States. The overlap between men who met the high specificity interstitial cystitis/bladder pain syndrome case definition or the chronic prostatitis/chronic pelvic pain syndrome case definition was 17%. Conclusions Symptoms of interstitial cystitis/bladder pain syndrome and chronic prostatitis/chronic pelvic pain syndrome are widespread among men in the United States. The prevalence of interstitial cystitis/bladder pain syndrome symptoms in men approaches that in women, suggesting that this condition may be underdiagnosed in the male population. |
Author | Berry, Sandra H Suskind, Anne M Suttorp, Marika J Elliott, Marc N Ewing, Brett A Clemens, J. Quentin |
AuthorAffiliation | Department of Urology, University of Michigan, Ann Arbor, MI RAND Corporation, Santa Monica, CA |
AuthorAffiliation_xml | – name: RAND Corporation, Santa Monica, CA – name: Department of Urology, University of Michigan, Ann Arbor, MI |
Author_xml | – sequence: 1 fullname: Suskind, Anne M – sequence: 2 fullname: Berry, Sandra H – sequence: 3 fullname: Ewing, Brett A – sequence: 4 fullname: Elliott, Marc N – sequence: 5 fullname: Suttorp, Marika J – sequence: 6 fullname: Clemens, J. Quentin |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=27199037$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/23164386$$D View this record in MEDLINE/PubMed |
BookMark | eNp9Ut1qFDEYHaRit9UX8ELmRvBmt0kmk8mIFOpatdDa0q3XIZt8082aTdZkZmHe0Mcy426rLVL4ICE5Px-cc5DtOe8gy15jNMEIs6PlZNkFPyEIkwniafizbIRLUo2LqiZ72QghQsZlQav97CDGJUKYlhV5ke2TAjNacDbKft0sIL8KsJEWnIJcOp1fbiBYuc59k5-5FkJsTWukzaf9n1s8-mil1hDyK2lcPuudDn61pU4XwTujkqKPrdyi79_AbobjASndL8C9z68hdraNg2ebNro--fbp_-b56dpoWBlv_W2fX6S181nb6f5l9ryRNsKr3XmYff98ejP9Oj6__HI2PTkfK1aQdsy0buaYSMI44bguNSKSKURL3HCiVMUJJVqRpmwYU_Wc1BTwnFYN5UAYBVIcZsdb3XU3X4FW4NogrVgHs5KhF14a8fDHmYW49RtR8JpWtEoC73YCwf_sILZiZaICa6UD30WBSVGjklGEEvTNv173JnfxJcDbHUBGJW0TpFMm_sVVuK5RMXjyLU6lXGKARigzxOOHFY0VGImhUWIphkaJoVEC8TQ8Uckj6p36k6QPWxKkJDYGgojKDP3SJoBqhfbmafrxI7qyJlVI2h_QQ1z6LriUscAiJo6YDT0fao4JohWqWPEbxwz91A |
CODEN | JOURAA |
CitedBy_id | crossref_primary_10_3389_fpain_2022_954967 crossref_primary_10_1016_j_juro_2015_11_012 crossref_primary_10_17650_2070_9781_2022_23_3_109_114 crossref_primary_10_1007_s10753_025_02247_y crossref_primary_10_4103_UROS_UROS_26_22 crossref_primary_10_1177_00099228241260119 crossref_primary_10_3390_toxins13050359 crossref_primary_10_1038_nrurol_2014_23 crossref_primary_10_3389_fpain_2022_925834 crossref_primary_10_1177_03915603231203431 crossref_primary_10_1186_s12894_020_00758_4 crossref_primary_10_1002_tox_24025 crossref_primary_10_1093_ptj_pzab015 crossref_primary_10_1155_2017_9472925 crossref_primary_10_1016_j_sxmr_2020_12_005 crossref_primary_10_1021_acs_molpharmaceut_8b00383 crossref_primary_10_1002_nau_25648 crossref_primary_10_1249_MSS_0000000000000472 crossref_primary_10_1016_S1634_7358_22_46550_8 crossref_primary_10_1038_nrurol_2016_227 crossref_primary_10_1016_j_urology_2018_02_039 crossref_primary_10_1371_journal_pone_0185686 crossref_primary_10_1111_bju_13457 crossref_primary_10_1111_bju_14783 crossref_primary_10_1007_s11884_016_0387_y crossref_primary_10_1002_nau_25550 crossref_primary_10_1007_s00345_023_04574_x crossref_primary_10_1007_s11255_023_03726_7 crossref_primary_10_1089_end_2020_0350 crossref_primary_10_17816_uroved626639 crossref_primary_10_1002_nau_25316 crossref_primary_10_1007_s11136_022_03183_2 crossref_primary_10_1177_17557380221111556 crossref_primary_10_3389_fmicb_2025_1488732 crossref_primary_10_1007_s11884_021_00640_5 crossref_primary_10_1097_AJP_0000000000001275 crossref_primary_10_3389_fpain_2021_810809 crossref_primary_10_1007_s00404_017_4364_2 crossref_primary_10_18553_jmcp_2017_23_4_474 crossref_primary_10_1002_14651858_CD012552_pub2 crossref_primary_10_33590_emjurol_20_00006 crossref_primary_10_1002_path_6040 crossref_primary_10_1097_SPV_0000000000000139 crossref_primary_10_1155_2020_5921038 crossref_primary_10_1016_j_cyto_2018_04_029 crossref_primary_10_2147_JPR_S370751 crossref_primary_10_1177_20552076231216280 crossref_primary_10_2217_pmt_14_21 crossref_primary_10_1016_j_acuroe_2018_06_003 crossref_primary_10_1097_MD_0000000000015678 crossref_primary_10_17116_klinderma20222101141 crossref_primary_10_3390_toxins14120838 crossref_primary_10_5498_wjp_v14_i6_954 crossref_primary_10_3748_wjg_v28_i48_6935 crossref_primary_10_1111_head_14099 crossref_primary_10_1007_s11884_021_00629_0 crossref_primary_10_3889_oamjms_2022_8230 crossref_primary_10_1055_a_2068_2687 crossref_primary_10_1111_iju_13975 crossref_primary_10_1177_17562872221109023 crossref_primary_10_1007_s00192_018_3574_x crossref_primary_10_4103_aja202427 crossref_primary_10_1007_s00192_019_04075_9 crossref_primary_10_1007_s00345_019_03045_6 crossref_primary_10_1111_luts_12214 crossref_primary_10_1007_s11884_024_00740_y crossref_primary_10_1016_j_jpsychores_2017_09_005 crossref_primary_10_1002_pros_23978 crossref_primary_10_1007_s11884_014_0287_y crossref_primary_10_1016_j_jpsychores_2014_10_003 crossref_primary_10_2147_IJGM_S351287 crossref_primary_10_1007_s11884_022_00673_4 crossref_primary_10_1371_journal_pone_0239282 crossref_primary_10_1089_end_2022_0396 crossref_primary_10_1111_bju_14988 crossref_primary_10_1124_jpet_123_002081 crossref_primary_10_1097_j_pain_0000000000002944 crossref_primary_10_1016_S1761_3310_13_65956_3 crossref_primary_10_1016_j_lfs_2020_117590 crossref_primary_10_1097_JWH_0000000000000307 crossref_primary_10_7759_cureus_69437 crossref_primary_10_1016_j_jpsychores_2018_06_013 crossref_primary_10_1146_annurev_physiol_020518_114525 crossref_primary_10_1038_s41585_023_00850_y crossref_primary_10_3389_fnsys_2022_882493 crossref_primary_10_1007_s00192_019_04036_2 crossref_primary_10_1186_s40887_020_00035_0 crossref_primary_10_3389_fpain_2024_1405488 crossref_primary_10_1016_j_juro_2015_01_086 crossref_primary_10_1016_j_bj_2021_06_006 crossref_primary_10_2147_JIR_S346855 crossref_primary_10_3390_jcm11216345 crossref_primary_10_1002_jcp_28009 crossref_primary_10_1016_j_juro_2014_11_016 crossref_primary_10_1089_end_2020_0605 crossref_primary_10_1007_s00192_019_03970_5 crossref_primary_10_1002_ggn2_202200013 crossref_primary_10_1016_j_juro_2017_09_167 crossref_primary_10_1016_j_urology_2021_07_019 crossref_primary_10_1002_14651858_CD012552 crossref_primary_10_1002_14651858_CD012551 crossref_primary_10_1002_14651858_CD012551_pub3 crossref_primary_10_62347_BLED2401 crossref_primary_10_1016_j_ejogrb_2021_05_038 crossref_primary_10_1002_14651858_CD012551_pub2 crossref_primary_10_5213_inj_2040104_052 crossref_primary_10_1155_2022_2069756 crossref_primary_10_1016_j_urology_2016_08_038 crossref_primary_10_1002_nau_24729 crossref_primary_10_1016_j_acuro_2018_01_008 crossref_primary_10_2147_IJGM_S417066 crossref_primary_10_1097_SPV_0000000000001166 crossref_primary_10_1007_s11884_024_00771_5 crossref_primary_10_1038_s41598_021_96810_w crossref_primary_10_3390_jcm13102884 crossref_primary_10_12688_f1000research_16096_1 crossref_primary_10_1111_bju_14492 crossref_primary_10_1186_1471_2490_14_58 crossref_primary_10_1097_MD_0000000000015199 crossref_primary_10_1186_1471_2490_14_57 crossref_primary_10_1016_j_apmt_2021_101144 crossref_primary_10_1002_14651858_CD012320 crossref_primary_10_1136_bmjopen_2024_088848 crossref_primary_10_1016_j_pnpbp_2017_05_012 crossref_primary_10_1016_j_cont_2023_101056 crossref_primary_10_21886_2308_6424_2023_11_2_65_73 crossref_primary_10_1002_nau_24983 crossref_primary_10_5483_BMBRep_2022_55_5_035 crossref_primary_10_1038_s41585_018_0135_5 crossref_primary_10_1007_s11884_013_0214_7 crossref_primary_10_1007_s11884_020_00596_y crossref_primary_10_1002_nau_24864 crossref_primary_10_1016_j_ejphar_2022_175052 crossref_primary_10_2147_RRU_S238746 crossref_primary_10_1007_s11884_014_0273_4 crossref_primary_10_1371_journal_pone_0309815 crossref_primary_10_1371_journal_pone_0217610 crossref_primary_10_1097_j_pain_0000000000001368 crossref_primary_10_1097_j_pain_0000000000003424 crossref_primary_10_1530_JOE_13_0422 crossref_primary_10_1016_S1636_5410_22_46457_9 crossref_primary_10_1177_1756287218818030 crossref_primary_10_2196_21909 crossref_primary_10_1007_s11255_022_03108_5 crossref_primary_10_1002_pros_23690 crossref_primary_10_1016_j_juro_2015_05_105 crossref_primary_10_2174_0115701808240328231031103739 crossref_primary_10_3390_jcm13020315 crossref_primary_10_14777_uti_2017_12_1_15 crossref_primary_10_1016_j_juro_2017_05_065 crossref_primary_10_1080_14740338_2021_1921733 crossref_primary_10_1016_j_sempedsurg_2019_150842 crossref_primary_10_1038_s41391_019_0196_4 crossref_primary_10_1007_s11884_023_00713_7 crossref_primary_10_1097_MD_0000000000016136 crossref_primary_10_3109_15360288_2014_972006 crossref_primary_10_1186_s12974_020_1704_0 crossref_primary_10_5534_wjmh_210078 crossref_primary_10_1080_01621459_2022_2066536 crossref_primary_10_17816_uroved107616 crossref_primary_10_3389_fimmu_2016_00140 crossref_primary_10_1016_j_urology_2018_07_046 crossref_primary_10_33590_emj_20_00029 crossref_primary_10_3390_diagnostics14232734 crossref_primary_10_1016_j_urology_2024_03_043 crossref_primary_10_1177_2051415813515810 crossref_primary_10_54133_ajms_v5i_243 crossref_primary_10_3390_toxins11110641 crossref_primary_10_1002_nau_24917 crossref_primary_10_1016_j_urology_2019_04_005 crossref_primary_10_1089_end_2019_0436 crossref_primary_10_1089_end_2021_0911 crossref_primary_10_1002_ejp_1942 crossref_primary_10_1111_and_14055 crossref_primary_10_3390_life12111693 crossref_primary_10_1111_luts_12395 crossref_primary_10_1016_j_juro_2016_03_003 crossref_primary_10_1097_MD_0000000000019540 crossref_primary_10_1177_17562872211022478 crossref_primary_10_3138_ptc_2022_0071 crossref_primary_10_4103_UROS_UROS_155_20 crossref_primary_10_1016_j_jpain_2022_03_240 crossref_primary_10_1007_s11655_020_3258_5 crossref_primary_10_1093_abm_kax060 crossref_primary_10_1038_tp_2016_168 crossref_primary_10_17816_uroved50229 crossref_primary_10_1517_13543784_2016_1162290 crossref_primary_10_3389_fpain_2021_748385 crossref_primary_10_3390_mps5030040 crossref_primary_10_1016_j_urology_2017_05_016 crossref_primary_10_1038_s41391_022_00559_w crossref_primary_10_1080_15360288_2022_2089437 crossref_primary_10_1016_j_ajur_2021_09_002 crossref_primary_10_3390_jcm9030766 crossref_primary_10_1038_s41598_018_22771_2 crossref_primary_10_2147_JPR_S396009 crossref_primary_10_1097_j_pain_0000000000003188 |
Cites_doi | 10.1016/j.juro.2006.03.089 10.1111/j.1464-410X.2007.07250.x 10.1016/j.juro.2008.04.002 10.1016/j.juro.2011.03.132 10.1016/j.juro.2009.12.103 10.1016/j.juro.2007.05.157 10.1016/S0090-4295(99)80327-6 10.1016/S0022-5347(05)64170-5 10.1097/01.ju.0000165170.43617.be 10.1016/j.juro.2010.02.168 10.1097/01.ju.0000146114.53828.82 10.1016/S0022-5347(05)66541-X 10.1016/j.juro.2007.01.124 10.1016/j.juro.2008.04.009 |
ContentType | Journal Article |
Copyright | American Urological Association Education and Research, Inc. 2013 American Urological Association Education and Research, Inc. 2014 INIST-CNRS Copyright © 2013 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved. |
Copyright_xml | – notice: American Urological Association Education and Research, Inc. – notice: 2013 American Urological Association Education and Research, Inc. – notice: 2014 INIST-CNRS – notice: Copyright © 2013 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved. |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.1016/j.juro.2012.08.088 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1527-3792 |
EndPage | 145 |
ExternalDocumentID | PMC3894747 23164386 27199037 10_1016_j_juro_2012_08_088 S0022534712047076 1_s2_0_S0022534712047076 |
Genre | Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: National Institute of Diabetes and Digestive and Kidney Diseases grantid: U10DK070234-01 – fundername: NIDDK NIH HHS grantid: U10DK070234-01 – fundername: NIDDK NIH HHS grantid: U01 DK070234 – fundername: National Institute of Diabetes and Digestive and Kidney Diseases : NIDDK grantid: U01 DK070234 || DK |
GroupedDBID | --- --K .55 .GJ .XZ 08P 0R~ 123 1B1 1CY 354 3O- 4.4 457 4G. 4Q1 4Q2 4Q3 53G 5RE 5VS 7-5 AAAAV AAEDT AAEDW AAGIX AAHPQ AAIQE AAJCS AAKAS AALRI AAMOA AAQFI AAQKA AAQQT AAQXK AASCR AASXQ AAXUO ABASU ABCQX ABDIG ABJNI ABLJU ABMAC ABOCM ABPPZ ABVCZ ABWVN ACGFS ACIJW ACILI ACLDA ACOAL ACRPL ACXJB ADGGA ADHPY ADMUD ADNKB ADNMO ADPAM ADZCM AEBDS AEETU AENEX AFDTB AFEXH AFFNX AFTRI AFUWQ AGHFR AHOMT AHQNM AHRYX AHVBC AI. AINUH AITUG AIZYK AJCLO AJIOK AJNWD AJZMW AKCTQ AKULP ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AMRAJ ASGHL ASPBG AVWKF AZFZN BCGUY BELOY BYPQX C45 C5W CS3 DIWNM DU5 EBS EEVPB EJD ERAAH EX3 F5P FCALG FDB FEDTE FGOYB GBLVA GNXGY GQDEL HLJTE HVGLF HZ~ H~9 IH2 IHE IKREB IKYAY IPNFZ J5H KMI L7B M41 MJL MO0 N4W NQ- NTWIH O9- OAG OAH OB3 OBH ODMTH OGROG OHH OL1 OVD OWU OWV OWW OWY OWZ P2P PKN QTD R2- RIG RLZ ROL RPZ SEL SES SJN SSZ TEORI TSPGW UDS UNMZH UV1 VH1 VVN WOW X7M XH2 XYM YFH YOC ZCG ZFV ZGI ZXP ZY1 ZZMQN AGZHU AHPSJ ALXNB ZA5 AAYXX ABPXF ABXYN ABZZY ACVFH ACZKN ADCNI ADGHP AFBFQ AFNMH AGQPQ AHQVU AIGII AOQMC CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 5PM |
ID | FETCH-LOGICAL-c632t-6ddfb12a26828195d02a6c0451f82cc78242dc2f5f66c9b294e1b47f48e264e23 |
ISSN | 0022-5347 1527-3792 |
IngestDate | Thu Aug 21 18:23:22 EDT 2025 Fri Jul 11 09:41:42 EDT 2025 Mon Jul 21 06:09:12 EDT 2025 Mon Jul 21 09:13:26 EDT 2025 Tue Jul 01 02:19:52 EDT 2025 Thu Apr 24 22:53:57 EDT 2025 Fri Feb 23 02:32:32 EST 2024 Sun Feb 23 10:18:47 EST 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | epidemiology Current Population Survey cystitis, interstitial prostatitis men chronic prostatitis/chronic pelvic pain syndrome CPS IC/BPS CP/CPPS interstitial cystitis/bladder pain syndrome Human Nephrology Urinary system disease Prevalence Prostate disease Male Urinary tract disease Pelvic pain Epidemiology Syndrome Urology Chronic Pain Urinary system Urinary bladder Adult Interstitial Prostatitis cystitis Male genital diseases Interstitial cystitis |
Language | English |
License | https://www.elsevier.com/tdm/userlicense/1.0 CC BY 4.0 Copyright © 2013 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c632t-6ddfb12a26828195d02a6c0451f82cc78242dc2f5f66c9b294e1b47f48e264e23 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/3894747 |
PMID | 23164386 |
PQID | 1239056400 |
PQPubID | 23479 |
PageCount | 5 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3894747 proquest_miscellaneous_1239056400 pubmed_primary_23164386 pascalfrancis_primary_27199037 crossref_citationtrail_10_1016_j_juro_2012_08_088 crossref_primary_10_1016_j_juro_2012_08_088 elsevier_sciencedirect_doi_10_1016_j_juro_2012_08_088 elsevier_clinicalkeyesjournals_1_s2_0_S0022534712047076 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2013-01-01 |
PublicationDateYYYYMMDD | 2013-01-01 |
PublicationDate_xml | – month: 01 year: 2013 text: 2013-01-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | New York, NY |
PublicationPlace_xml | – name: New York, NY – name: United States |
PublicationTitle | The Journal of urology |
PublicationTitleAlternate | J Urol |
PublicationYear | 2013 |
Publisher | Elsevier Inc Elsevier |
Publisher_xml | – name: Elsevier Inc – name: Elsevier |
References | Hall, Link, Pulliam (bib10) 2008; 180 Clemens, Meenan, Rosetti (bib8) 2005; 173 Jones, Nyberg (bib6) 1997; 49 Clemens, Hilton, Suttorp (bib4) 2010; 183 Clemens, Meenan, O'Keeffe Rosetti (bib9) 2005; 174 Walz, Perrotte, Hutterer (bib15) 2007; 100 Clemens, Markossian, Meenan (bib16) 2007; 178 Clemens, Meenan, O'Keeffe-Rosetti (bib13) 2006; 176 Link, Pulliam, Hanno (bib1) 2008; 180 bib5 Berry, Bogart, Pham (bib2) 2010; 183 Berry, Elliott, Suttorp (bib11) 2011; 186 Nickel, Downey, Hunter (bib3) 2001; 165 Roberts, Jacobson, Girman (bib12) 2002; 168 Payne, Joyce, Wise (bib7) 2007; 177 Daniels, Link, Barry (bib14) 2007; 99 Clemens (10.1016/j.juro.2012.08.088_bib13) 2006; 176 Link (10.1016/j.juro.2012.08.088_bib1) 2008; 180 Hall (10.1016/j.juro.2012.08.088_bib10) 2008; 180 Jones (10.1016/j.juro.2012.08.088_bib6) 1997; 49 Clemens (10.1016/j.juro.2012.08.088_bib8) 2005; 173 Roberts (10.1016/j.juro.2012.08.088_bib12) 2002; 168 Walz (10.1016/j.juro.2012.08.088_bib15) 2007; 100 Clemens (10.1016/j.juro.2012.08.088_bib4) 2010; 183 Nickel (10.1016/j.juro.2012.08.088_bib3) 2001; 165 Payne (10.1016/j.juro.2012.08.088_bib7) 2007; 177 Berry (10.1016/j.juro.2012.08.088_bib11) 2011; 186 Clemens (10.1016/j.juro.2012.08.088_bib9) 2005; 174 Clemens (10.1016/j.juro.2012.08.088_bib16) 2007; 178 Berry (10.1016/j.juro.2012.08.088_bib2) 2010; 183 Daniels (10.1016/j.juro.2012.08.088_bib14) 2007; 99 21683389 - J Urol. 2011 Aug;186(2):540-4 19524948 - J Urol. 2009 Aug;182(2):558-63 17706719 - J Urol. 2007 Oct;178(4 Pt 1):1354-8; discussion 1358 11176483 - J Urol. 2001 Mar;165(3):842-5 16813895 - J Urol. 2006 Aug;176(2):593-6; discussion 596 16469592 - J Urol. 2006 Mar;175(3 Pt 1):963-6; discussion 967 16006901 - J Urol. 2005 Aug;174(2):576-80 10411041 - J Urol. 1999 Aug;162(2):369-75 19007369 - BJU Int. 2009 Apr;103(8):1080-4 17010006 - Int J Urol. 2006 Oct;13(10):1286-9 17941922 - BJU Int. 2007 Dec;100(6):1307-11 20303099 - J Urol. 2010 May;183(5):1848-52 12441942 - J Urol. 2002 Dec;168(6):2467-71 18554658 - J Urol. 2008 Aug;180(2):599-606 9586610 - Urology. 1998 Apr;51(4):578-84 17509284 - J Urol. 2007 Jun;177(6):2042-9 18554659 - J Urol. 2008 Aug;180(2):593-8 12559266 - Urology. 2003 Jan;61(1):60-4 17534008 - J Natl Med Assoc. 2007 May;99(5):509-16 18395963 - Eur Urol. 2009 Feb;55(2):499-507 9145997 - Urology. 1997 May;49(5A Suppl):2-9 15592041 - J Urol. 2005 Jan;173(1):98-102; discussion 102 |
References_xml | – volume: 168 start-page: 2467 year: 2002 ident: bib12 article-title: Prevalence of prostatitis-like symptoms in a community based cohort of older men publication-title: J Urol – volume: 183 start-page: 1848 year: 2010 ident: bib2 article-title: Development, validation and testing of an epidemiological case definition of interstitial cystitis/painful bladder syndrome publication-title: J Urol – ident: bib5 article-title: General demographic characteristics, 2006 – volume: 176 start-page: 593 year: 2006 ident: bib13 article-title: Prevalence of prostatitis-like symptoms in a managed care population publication-title: J Urol – volume: 49 start-page: 2 year: 1997 ident: bib6 article-title: Epidemiology of interstitial cystitis publication-title: Urology – volume: 165 start-page: 842 year: 2001 ident: bib3 article-title: Prevalence of prostatitis-like symptoms in a population based study using the National Institutes of Health chronic prostatitis symptom index publication-title: J Urol – volume: 173 start-page: 98 year: 2005 ident: bib8 article-title: Prevalence and incidence of interstitial cystitis in a managed care population publication-title: J Urol – volume: 178 start-page: 1354 year: 2007 ident: bib16 article-title: Overlap of voiding symptoms, storage symptoms and pain in men and women publication-title: J Urol – volume: 180 start-page: 599 year: 2008 ident: bib1 article-title: Prevalence and psychosocial correlates of symptoms suggestive of painful bladder syndrome: results from the Boston area community health survey publication-title: J Urol – volume: 186 start-page: 540 year: 2011 ident: bib11 article-title: Prevalence of symptoms of bladder pain syndrome/interstitial cystitis among adult females in the United States publication-title: J Urol – volume: 177 start-page: 2042 year: 2007 ident: bib7 article-title: Interstitial cystitis and painful bladder syndrome publication-title: J Urol – volume: 100 start-page: 1307 year: 2007 ident: bib15 article-title: Impact of chronic prostatitis-like symptoms on the quality of life in a large group of men publication-title: BJU Int – volume: 180 start-page: 593 year: 2008 ident: bib10 article-title: The relationship of common medical conditions and medication use with symptoms of painful bladder syndrome: results from the Boston area community health survey publication-title: J Urol – volume: 99 start-page: 509 year: 2007 ident: bib14 article-title: Association between past urinary tract infections and current symptoms suggestive of chronic prostatitis/chronic pelvic pain syndrome publication-title: JAMA – volume: 183 start-page: e48 year: 2010 ident: bib4 article-title: Identifying chronic prostatitis/chronic pelvic pain syndrome for epidemiologic studies publication-title: J Urol – volume: 174 start-page: 576 year: 2005 ident: bib9 article-title: Prevalence of interstitial cystitis symptoms in a managed care population publication-title: J Urol – volume: 176 start-page: 593 year: 2006 ident: 10.1016/j.juro.2012.08.088_bib13 article-title: Prevalence of prostatitis-like symptoms in a managed care population publication-title: J Urol doi: 10.1016/j.juro.2006.03.089 – volume: 100 start-page: 1307 year: 2007 ident: 10.1016/j.juro.2012.08.088_bib15 article-title: Impact of chronic prostatitis-like symptoms on the quality of life in a large group of men publication-title: BJU Int doi: 10.1111/j.1464-410X.2007.07250.x – volume: 180 start-page: 593 year: 2008 ident: 10.1016/j.juro.2012.08.088_bib10 article-title: The relationship of common medical conditions and medication use with symptoms of painful bladder syndrome: results from the Boston area community health survey publication-title: J Urol doi: 10.1016/j.juro.2008.04.002 – volume: 186 start-page: 540 year: 2011 ident: 10.1016/j.juro.2012.08.088_bib11 article-title: Prevalence of symptoms of bladder pain syndrome/interstitial cystitis among adult females in the United States publication-title: J Urol doi: 10.1016/j.juro.2011.03.132 – volume: 183 start-page: 1848 year: 2010 ident: 10.1016/j.juro.2012.08.088_bib2 article-title: Development, validation and testing of an epidemiological case definition of interstitial cystitis/painful bladder syndrome publication-title: J Urol doi: 10.1016/j.juro.2009.12.103 – volume: 178 start-page: 1354 year: 2007 ident: 10.1016/j.juro.2012.08.088_bib16 article-title: Overlap of voiding symptoms, storage symptoms and pain in men and women publication-title: J Urol doi: 10.1016/j.juro.2007.05.157 – volume: 49 start-page: 2 year: 1997 ident: 10.1016/j.juro.2012.08.088_bib6 article-title: Epidemiology of interstitial cystitis publication-title: Urology doi: 10.1016/S0090-4295(99)80327-6 – volume: 168 start-page: 2467 year: 2002 ident: 10.1016/j.juro.2012.08.088_bib12 article-title: Prevalence of prostatitis-like symptoms in a community based cohort of older men publication-title: J Urol doi: 10.1016/S0022-5347(05)64170-5 – volume: 174 start-page: 576 year: 2005 ident: 10.1016/j.juro.2012.08.088_bib9 article-title: Prevalence of interstitial cystitis symptoms in a managed care population publication-title: J Urol doi: 10.1097/01.ju.0000165170.43617.be – volume: 183 start-page: e48 issue: suppl. year: 2010 ident: 10.1016/j.juro.2012.08.088_bib4 article-title: Identifying chronic prostatitis/chronic pelvic pain syndrome for epidemiologic studies publication-title: J Urol doi: 10.1016/j.juro.2010.02.168 – volume: 173 start-page: 98 year: 2005 ident: 10.1016/j.juro.2012.08.088_bib8 article-title: Prevalence and incidence of interstitial cystitis in a managed care population publication-title: J Urol doi: 10.1097/01.ju.0000146114.53828.82 – volume: 165 start-page: 842 year: 2001 ident: 10.1016/j.juro.2012.08.088_bib3 article-title: Prevalence of prostatitis-like symptoms in a population based study using the National Institutes of Health chronic prostatitis symptom index publication-title: J Urol doi: 10.1016/S0022-5347(05)66541-X – volume: 177 start-page: 2042 year: 2007 ident: 10.1016/j.juro.2012.08.088_bib7 article-title: Interstitial cystitis and painful bladder syndrome publication-title: J Urol doi: 10.1016/j.juro.2007.01.124 – volume: 99 start-page: 509 year: 2007 ident: 10.1016/j.juro.2012.08.088_bib14 article-title: Association between past urinary tract infections and current symptoms suggestive of chronic prostatitis/chronic pelvic pain syndrome publication-title: JAMA – volume: 180 start-page: 599 year: 2008 ident: 10.1016/j.juro.2012.08.088_bib1 article-title: Prevalence and psychosocial correlates of symptoms suggestive of painful bladder syndrome: results from the Boston area community health survey publication-title: J Urol doi: 10.1016/j.juro.2008.04.009 – reference: 9145997 - Urology. 1997 May;49(5A Suppl):2-9 – reference: 19524948 - J Urol. 2009 Aug;182(2):558-63 – reference: 21683389 - J Urol. 2011 Aug;186(2):540-4 – reference: 15592041 - J Urol. 2005 Jan;173(1):98-102; discussion 102 – reference: 17941922 - BJU Int. 2007 Dec;100(6):1307-11 – reference: 19007369 - BJU Int. 2009 Apr;103(8):1080-4 – reference: 11176483 - J Urol. 2001 Mar;165(3):842-5 – reference: 17706719 - J Urol. 2007 Oct;178(4 Pt 1):1354-8; discussion 1358 – reference: 18554659 - J Urol. 2008 Aug;180(2):593-8 – reference: 16006901 - J Urol. 2005 Aug;174(2):576-80 – reference: 17534008 - J Natl Med Assoc. 2007 May;99(5):509-16 – reference: 10411041 - J Urol. 1999 Aug;162(2):369-75 – reference: 16469592 - J Urol. 2006 Mar;175(3 Pt 1):963-6; discussion 967 – reference: 12559266 - Urology. 2003 Jan;61(1):60-4 – reference: 12441942 - J Urol. 2002 Dec;168(6):2467-71 – reference: 17010006 - Int J Urol. 2006 Oct;13(10):1286-9 – reference: 17509284 - J Urol. 2007 Jun;177(6):2042-9 – reference: 9586610 - Urology. 1998 Apr;51(4):578-84 – reference: 18554658 - J Urol. 2008 Aug;180(2):599-606 – reference: 20303099 - J Urol. 2010 May;183(5):1848-52 – reference: 16813895 - J Urol. 2006 Aug;176(2):593-6; discussion 596 – reference: 18395963 - Eur Urol. 2009 Feb;55(2):499-507 |
SSID | ssj0014572 |
Score | 2.509755 |
Snippet | Purpose As part of the RICE (RAND Interstitial Cystitis Epidemiology) study, we developed validated case definitions to identify interstitial cystitis/bladder... As part of the RICE (RAND Interstitial Cystitis Epidemiology) study, we developed validated case definitions to identify interstitial cystitis/bladder pain... |
SourceID | pubmedcentral proquest pubmed pascalfrancis crossref elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 141 |
SubjectTerms | Adolescent Adult Aged Biological and medical sciences cystitis, interstitial Cystitis, Interstitial - complications Cystitis, Interstitial - epidemiology epidemiology Humans Male Medical sciences men Middle Aged Nephrology. Urinary tract diseases Prevalence prostatitis Prostatitis - complications Prostatitis - epidemiology Urinary system involvement in other diseases. Miscellaneous Urinary tract. Prostate gland Urology Young Adult |
Title | The Prevalence and Overlap of Interstitial Cystitis/Bladder Pain Syndrome and Chronic Prostatitis/Chronic Pelvic Pain Syndrome in Men: Results of the RAND Interstitial Cystitis Epidemiology Male Study |
URI | https://www.clinicalkey.es/playcontent/1-s2.0-S0022534712047076 https://dx.doi.org/10.1016/j.juro.2012.08.088 https://www.ncbi.nlm.nih.gov/pubmed/23164386 https://www.proquest.com/docview/1239056400 https://pubmed.ncbi.nlm.nih.gov/PMC3894747 |
Volume | 189 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKJiEkhLhTLpOReKu6NY5z422dOgaCPbAN7S1yUlu0tGmUNqDxC_kL_BvOiZ3E7S4CXlrLsRNb5_PJZ-fzMSFvpO8k4yRUfT-FuSoHRtsXKUfNlHKUEiLwZKXyPfaPzviHc--80_ltqZbKVbKb_rxyX8n_WBXywK64S_YfLNvcFDIgDfaFX7Aw_P61jfMCA3bLWviPisyZyOtIEAVKAXBRPL2oUmC1w2SG3qbo5WKSNREL9P42HSkXRVu40ciUb3Ll7Dv-rVWD9FxW6hCYt5czrQxBMvsZ41a9t5twYJrQG7Wn0l705tB4K8jttO2ZxZXLYm31_6RcfpvUgkxgyc3q0VAWWhZwAt0pRLvzYvTDnN0yRGFyu4BrS1YwasGxvQqCJ1I0qyDSeG6G3jLacO3RJQxrR-3ocFuXXiB6LWO6O4WOofCPVQFe9cmDFqLyeQUpIMfA6DZjeVfsoL50i2wzmMGAC95-N_z4Zb_5xAXjgpldXFpwuPlIjFNtbnIdabqbiyUMZaXPYLlqkrSp9bXI0-l9cs9Yku5rCD8gHZk9JLc_GV3HI_IL7E1bJFOwHjVIpgtFbSTTGsl7BscUAUlrQFZVDWKpheO9Jq9C8UYlSAOK31KDYXwmYJgihqmNYVpjmNoYpohhWmH4MTk7HJ0eHPXNGSP91HfZqu-PxypxmGB-WH1SHg-YALfFPUeFLE2BP3M2TpnylO-nUcIiLp2EB4qHEqYSkrlPyFa2yOQzQhM_dZwEKKHrJkCLIyDCHlcRF2rABR-ILnFqI8apCcCP58DM4lppOY0RAzFiIMbDYcOwS3pNnVyHn7mxdFBjI643VgMVkEvjs5axEy-hcIwSDea5QEzZgAeDwO8Sr6lpqLem1DEMjBufuLMGwaaRLHCA57pBl7yuMRnDiwu_RopMLkpoCnMjmH0Bh-iSpxqjbW2De-jQGnqbAhgUf_1KNvlaBceHCRgPePD82nu-IHdaB_KSbK2KUr6CicUq2TFD9A_P2C-t |
linkProvider | Elsevier |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+prevalence+and+overlap+of+interstitial+cystitis%2Fbladder+pain+syndrome+and+chronic+prostatitis%2Fchronic+pelvic+pain+syndrome+in+men%3A+results+of+the+RAND+Interstitial+Cystitis+Epidemiology+male+study&rft.jtitle=The+Journal+of+urology&rft.au=Suskind%2C+Anne+M&rft.au=Berry%2C+Sandra+H&rft.au=Ewing%2C+Brett+A&rft.au=Elliott%2C+Marc+N&rft.date=2013-01-01&rft.eissn=1527-3792&rft.volume=189&rft.issue=1&rft.spage=141&rft_id=info:doi/10.1016%2Fj.juro.2012.08.088&rft_id=info%3Apmid%2F23164386&rft.externalDocID=23164386 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00225347%2FS0022534712X00028%2Fcov150h.gif |